RCM Capital

Managing Partner Christopher Morris leads investment decisions. He founded the firm in 2009 after investment banking at Credit Suisse First Boston in London and operating roles at Hollinger International and Torstar Corporation. Morris holds a PhD from Cambridge University. Partner Conrad Krebs, who joined at inception, is the other named principal.

The firm states it relies on 'patient and long-term investors' alongside its own capital but does not disclose a formal fund structure. RCM began making its own investments in 2011 and has focused exclusively on direct investing since 2015. The exact mix of internal versus external capital is not publicly disclosed.

RCM executes direct debt investments in special situations — restructuring, turnaround, and complex transactions that fall outside standard investor mandates. The firm emphasizes creativity, flexibility, and a willingness to work through difficult structures that other capital providers cannot or will not handle.

The firm relies on a network of professionals who bring transactions directly to the team. RCM's website notes that its success depends on these intermediaries and on maintaining good relationships with investee companies. The group does not publish portfolio holdings or named sourcing partners.

RCM is headquartered in Vancouver with an additional office in Toronto. The firm's investment activity is not confined to Canada — its principals' backgrounds and sourcing network suggest cross-border execution capability, though specific geographic exposures are not disclosed.

The firm describes its capital as patient and long-term, noting that its investments 'take work, flexibility, and creativity to complete' and require 'care, patience, problem-solving and goodwill' to succeed over time. This implies multi-year holding periods without fixed exit timelines.

No. RCM is a private asset management firm, not a single-family or multi-family office. The principals do not disclose any connection to a specific family wealth source, and the firm describes its investor base broadly as patient, long-term capital providers.